论文部分内容阅读
目的观察微生态制剂治疗早产儿喂养不耐受患儿的临床表现及效果。方法选取住院喂养不耐受的早产儿62例,随机分为治疗组32例和对照组30例,两组均按照常规护理和治疗,并予静脉营养的同时,治疗组在喂奶后予微生态制剂双歧三联活菌片0.5 g,3次/d,疗程5~7 d。结果治疗组患儿经过治疗,呕吐、胃潴留、腹胀、症状缓解、体重增长、静脉营养和住院天数等方面比较均好于对照组,且对比差异有统计学意义(P均<0.05)。结论应用微生态制剂治疗喂养不耐受早产儿效果确切,无副作用,未发现不良反应以及并发症;且体重增长明显,缩短了住院日,减轻了患者的经济负担,特别适用基层医院,值得临床推广应用。
Objective To observe the clinical manifestations and effects of probiotics in treating infants with premature infants intolerant. Methods 62 cases of preterm infants who were intolerant to hospitalization were selected and randomly divided into treatment group (32 cases) and control group (30 cases). Both groups were treated according to the routine nursing and treatment and given intravenous nutrition. At the same time, Bifidobacterium triple viable tablets 0.5 g, 3 times / d, treatment of 5 ~ 7 d. Results The treatment group was better than the control group in the treatment of vomiting, gastric retention, bloating, symptom relief, weight gain, parenteral nutrition and length of hospital stay, and the difference was statistically significant (all P <0.05). Conclusion The application of probiotics in the treatment of premature infants with intolerance has the exact effect, no side effects, no adverse reactions and complications; and significant weight gain, shorten the hospitalization days and reduce the economic burden on patients, especially for primary hospitals, it is worth clinical Promote the application.